Talking to patients about Lenacapavir (Sunlenca); the new long-acting injectable medication for HIV

Talking to patients about Lenacapavir (Sunlenca); the new long-acting injectable medication for HIV

In this episode, Dr. Steven Fine, an infectious disease specialist affiliated with the University of Rochester and Anthony Jordan Health Center explains the pros and cons behind the newly approved Lenacapavir (Sunlenca) injectable for HIV. Dr. Fine receives a lot of questions about the medication in his practice. Many patients have heard good things about the new treatment for HIV that is given as a subcutaneous injection once every 6 months. Dr. Fine discusses the current indication in combination with other agents for “treatment-experienced” HIV patients and possible future uses. You’ll hear about Lenacapavir, the data that led to approval, and how it may be used in the future - including possibly for Pre-Exposure Prophylaxis (PrEP).

Related Content:

Jaksot(58)

How Can We Destigmatize HIV and Pregnancy?

How Can We Destigmatize HIV and Pregnancy?

Preventing perinatal HIV transmission is an important strategy for eliminating HIV. Historically, rates of perinatal HIV transmission were 25-40% without interventions, but advances in HIV research, p...

8 Joulu 202227min

Taking the Next Step: Providing Proactive Reproductive Health Care in Your Clinical Setting

Taking the Next Step: Providing Proactive Reproductive Health Care in Your Clinical Setting

Reproductive healthcare is a critical part of healthcare overall. Yet components of this care, including abortion, are becoming more and more inaccessible to certain parts of the population, worsened ...

10 Marras 202238min

Universal Hepatitis C Screening among Pregnant Persons: The Time is Now

Universal Hepatitis C Screening among Pregnant Persons: The Time is Now

Hepatitis C is the most commonly reported blood-borne infection in the US, responsible for more deaths than all 60 reportable infectious diseases combined. Once most prevalent among “Baby Boomers” or ...

11 Loka 202227min

Some Basics About HIV-Hepatitis B Co-Infection

Some Basics About HIV-Hepatitis B Co-Infection

HIV and Hepatitis B share similar routes of transmission. In United States, a large cohort study of patients with HIV showed that over 10 % of men who had sex with men, over 8% of those who injected d...

15 Syys 202230min

Where are we with an HIV vaccine and cure?

Where are we with an HIV vaccine and cure?

Despite the existence of medications that can control HIV and even reduce viral transmission, HIV is still a leading cause of death and a health threat to millions worldwide. The goal of this episode ...

11 Elo 202245min

Check Yourself! Bringing STI Home Testing to Your Patients

Check Yourself! Bringing STI Home Testing to Your Patients

The COVID-19 pandemic substantially impacted the capacity of sexual health clinics across the nation. It also provided insight into the availability and demand for at-home health testing. The National...

14 Heinä 202235min

There is Love in the Overdose Prevention Center

There is Love in the Overdose Prevention Center

The number of drug overdose deaths in the US more than quadrupled between 2000 and 2019, and opioid overdose was declared a national public health emergency in 2017. Nationally, overdose deaths were t...

9 Kesä 20221h 6min

Exciting Injectable PrEP for HIV; No More Pills!

Exciting Injectable PrEP for HIV; No More Pills!

Access to PrEP is a pillar of the NYSDOH End the Epidemic initiative, that emphasizes the safety and effectiveness of PrEP as a method to prevent HIV infection. However, structural and individual barr...

12 Touko 202229min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
adhd-podi
rss-narsisti
psykologia
kesken
rahapuhetta
rss-niinku-asia-on
rss-vapaudu-voimaasi
rss-liian-kuuma-peruna
rss-duodecim-lehti
rss-luonnollinen-synnytys-podcast
rss-tietoinen-yhteys-podcast-2
aamukahvilla
rss-uskonto-on-tylsaa
rss-valo-minussa-2
rss-honest-talk-with-laurrenna
rss-opeklubi
rss-psykalab